Cardiomyopathy and carnitine deficiency

Molecular Genetics and Metabolism

Volumn 94, Issue 2, 2008, Pages 162-166

  Amat di San Filippo, Cristina ^a   Taylor, Matthew R G ^b   Mestroni, Luisa ^b   Botto, Lorenzo D ^a   Longo, Nicola ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiomyopathy; Carnitine; Carnitine transporter; OCTN2; SLC22A5

Indexed keywords

CARNITINE; CARRIER PROTEIN; FLUORESCENT DYE; OCTN2 CARNITINE TRANSPORTER PROTEIN;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CARDIOMYOPATHY; CARNITINE DEFICIENCY; CHO CELL; CONTROLLED STUDY; DENATURATION; DISEASE ASSOCIATION; EXON; FEMALE; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SLC22A5 GENE;

ANIMALS; CARDIOMYOPATHIES; CARNITINE; CHO CELLS; CRICETINAE; CRICETULUS; EXONS; GENE EXPRESSION; HETEROZYGOTE; HUMANS; MUTATION, MISSENSE; ORGANIC CATION TRANSPORT PROTEINS; POLYMERASE CHAIN REACTION;

ANIMALIA; CRICETULUS GRISEUS;

EID: 43249131871     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2008.02.002     Document Type: Article

References (25)

1. Roe C., and Ding J. Mitochondrial fatty acid oxidation disorders. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York 2297-2326
2. Scaglia F., and Longo N. Primary and secondary alterations of neonatal carnitine metabolism. Semin. Perinatol. 23 (1999) 152-161
3. Koizumi A., Nozaki J., Ohura T., Kayo T., Wada Y., Nezu J., Ohashi R., Tamai I., Shoji Y., Takada G., Kibira S., Matsuishi T., and Tsuji A. Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum. Mol. Genet. 8 (1999) 2247-2254
4. Wilcken B., Wiley V., Sim K.G., and Carpenter K. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J. Pediatr. 138 (2001) 581-584
5. Wilcken B., Wiley V., Hammond J., and Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N. Engl. J. Med. 348 (2003) 2304-2312
6. Tamai I., Ohashi R., Nezu J., Yabuuchi H., Oku A., Shimane M., Sai Y., and Tsuji A. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 273 (1998) 20378-20382
7. Wu X., Prasad P.D., Leibach F.H., and Ganapathy V. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem. Biophys. Res. Commun. 246 (1998) 589-595
8. Scaglia F., Wang Y., Singh R.H., Dembure P.P., Pasquali M., Fernhoff P.M., and Longo N. Defective urinary carnitine transport in heterozygotes for primary carnitine deficiency. Genet. Med. 1 (1998) 34-39
9. Longo N., Amat di San Filippo C., and Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am. J. Med. Genet. C Semin. Med. Genet. 142 (2006) 77-85
10. Kuwajima M., Kono N., Horiuchi M., Imamura Y., Ono A., Inui Y., Kawata S., Koizumi T., Hayakawa J., Saheki T., et al. Animal model of systemic carnitine deficiency: analysis in C3H-H-2 degrees strain of mouse associated with juvenile visceral steatosis. Biochem. Biophys. Res. Commun. 174 (1991) 1090-1094
11. +/- mutant mouse livers. Mol. Genet. Metab. 76 (2002) 76-80
12. Xiaofei E., Wada Y., Dakeishi M., Hirasawa F., Murata K., Masuda H., Sugiyama T., Nikaido H., and Koizumi A. Age-associated cardiomyopathy in heterozygous carrier mice of a pathological mutation of carnitine transporter gene, OCTN2. J. Gerontol. A Biol. Sci. Med. Sci. 57 (2002) B270-B278
13. Takahashi R., Asai T., Murakami H., Murakami R., Tsuzuki M., Numaguchi Y., Matsui H., Murohara T., and Okumura K. Pressure overload-induced cardiomyopathy in heterozygous carrier mice of carnitine transporter gene mutation. Hypertension 50 (2007) 497-502
14. Mestroni L., Maisch B., McKenna W.J., Schwartz K., Charron P., Rocco C., Tesson F., Richter A., Wilke A., and Komajda M. Guidelines for the study of familial dilated cardiomyopathies. Collaborative research group of the European human and capital mobility project on familial dilated cardiomyopathy. Eur. Heart J. 20 (1999) 93-102
15. Ku L., Feiger J., Taylor M., and Mestroni L. Cardiology patient page. Familial dilated cardiomyopathy. Circulation 108 (2003) e118-e121
16. Amat di San Filippo C., Pasquali M., and Longo N. Pharmacological rescue of carnitine transport in primary carnitine deficiency. Hum. Mutat. 27 (2006) 513-523
17. Dobrowolski S.F., McKinney J.T., Amat di San Filippo C., Giak Sim K., Wilcken B., and Longo N. Validation of dye-binding/high-resolution thermal denaturation for the identification of mutations in the SLC22A5 gene. Hum. Mutat. 25 (2005) 306-313
18. Wang Y., Meadows T.A., and Longo N. Abnormal sodium stimulation of carnitine transport in primary carnitine deficiency. J. Biol. Chem. 275 (2000) 20782-20786
19. Amat Di San Filippo C., and Longo N. Tyrosine residues affecting sodium stimulation of carnitine transport in the OCTN2 carnitine/organic cation transporter. J. Biol. Chem. 279 (2004) 7247-7253
20. Wang Y., Kelly M.A., Cowan T.M., and Longo N. A missense mutation in the OCTN2 gene associated with residual carnitine transport activity. Hum. Mutat. 15 (2000) 238-245
21. Wang Y., Taroni F., Garavaglia B., and Longo N. Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation. Hum. Mutat. 16 (2000) 401-407
22. Wang Y., Korman S.H., Ye J., Gargus J.J., Gutman A., Taroni F., Garavaglia B., and Longo N. Phenotype and genotype variation in primary carnitine deficiency. Genet. Med. 3 (2001) 387-392
23. Urban T.J., Gallagher R.C., Brown C., Castro R.A., Lagpacan L.L., Brett C.M., Taylor T.R., Carlson E.J., Ferrin T.E., Burchard E.G., Packman S., and Giacomini K.M. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5). Mol. Pharmacol. 70 (2006) 1602-1611
24. Schimmenti L.A., Crombez E.A., Schwahn B.C., Heese B.A., Wood T.C., Schroer R.J., Bentler K., Cederbaum S., Sarafoglou K., McCann M., Rinaldo P., Matern D., di San Filippo C.A., Pasquali M., Berry S.A., and Longo N. Expanded newborn screening identifies maternal primary carnitine deficiency. Mol. Genet. Metab. 90 4 (2006) 441-445
25. Wynne J., and Braunwald E. Cardiomyopathy and myocarditis. In: Kasper D., Braunwald E., Fauci A., Hauser S., Longo D., and Jameson J. (Eds). Harrison's Principles of Internal Medicine (2005), McGraw-Hill, New York 1408-1414